Healthcare Sector

PFE

Market Tracker

$26.37
+0.27
(+1.03%)
12:20 pm
Next Earnings: (est.) 08/01/23 12:00 am
  • PFE (Selected)

    Pfizer Inc.
  • PFEB

    Innovator S&P 500 Power Buffer ETF - February

PFE Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

PFE Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

PFE Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

PFE Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

PFE Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

PFE Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
02/06/2026 CALL $26.00 11,769 +1,829 +18.40%
06/18/2026 PUT $26.00 4,781 +1,198 +33.44%
03/20/2026 PUT $25.00 31,705 +1,066 +3.48%
06/18/2026 CALL $31.00 1,931 +963 +99.48%
01/30/2026 CALL $28.00 7,425 +952 +14.71%
02/06/2026 CALL $26.50 6,709 +917 +15.83%
02/13/2026 CALL $28.00 672 -180 -21.13%
02/06/2026 CALL $28.00 2,276 -233 -9.29%
06/18/2026 CALL $30.00 49,476 -370 -0.74%
01/15/2027 CALL $20.00 10,814 -422 -3.76%
01/30/2026 PUT $25.50 6,011 -603 -9.12%
01/30/2026 CALL $26.00 17,127 -3,507 -17.00%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

PFE Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.02% 170.64M 6.14B
Vanguard 500 Index Fund 2.30% 129.76M 4.67B
Washington Mutual Investors Fund 1.42% 80.41M 2.89B
Fidelity 500 Index Fund 1.09% 61.54M 2.21B
SPDR S&P 500 ETF Trust 1.08% 60.77M 2.19B
American Balanced Fund 1.00% 56.61M 2.04B
Income Fund of America Inc 0.93% 52.68M 1.9B
iShares Core S&P 500 ETF 0.89% 50.1M 1.8B
Vanguard Index-Value Index Fund 0.86% 48.51M 1.75B
Vanguard Specialized-Health Care Fund 0.86% 48.32M 1.74B

PFE News

  • This Top Dividend Stock Could Achieve a Major Milestone This Year. Is It a Buy?

    01/30 11:18 pm

    The Motley Fool

    Read more
  • This Beaten-Down Biotech Is Showing Signs of Life. Is It a Buy?

    01/29 09:30 am

    The Motley Fool

    Read more
  • 3 High-Yield Stocks to Buy Hand Over Fist in January

    01/29 08:03 am

    The Motley Fool

    Read more
  • This Could Be 1 of the Best Pharmaceutical Stock-Buying Opportunities I've Seen in Years

    01/28 08:03 pm

    The Motley Fool

    Read more
  • Sleeping Bruxism Treatment Market Size to Reach USD 1,132.09 Million by 2033, Driven by Rising Awareness of Sleep Disorders and Oral Health Complications – SNS Insider

    01/28 07:00 am

    GlobeNewswire Inc.

    Read more
  • Atopic Dermatitis Market to Reach USD 12.97 Billion by 2034, Growing at 7.75% CAGR

    01/27 11:00 am

    GlobeNewswire Inc.

    Read more
  • Where Will Eli Lilly Be in 10 Years?

    01/27 10:07 am

    The Motley Fool

    Read more
  • Cogent's New Stomach Cancer Treatment Cuts Progression Risk In Half, Gets Breakthrough Therapy Tag

    01/26 11:06 am

    Benzinga

    Read more
  • The Best Stocks to Invest $40 in to Start the New Year Off Right

    01/24 02:15 pm

    The Motley Fool

    Read more
  • Pfizer CEO Calls RFK's Vaccine Views Anti-Science, Warns US Falling Behind China In Health Research

    01/23 01:36 pm

    Benzinga

    Read more
  • Lipid Nanoparticle Manufacturing Market: An 18.9% CAGR Market Driven by Nucleic Acid Therapies

    01/23 11:00 am

    GlobeNewswire Inc.

    Read more
  • FDA Approves Guardant Health's Blood Test To Guide Treatment For Advanced Colorectal Cancer

    01/22 01:51 pm

    Benzinga

    Read more
  • Postpartum Depression Drugs Market Size to Surpass USD 1.97 Billion by 2033, Due to Increasing Awareness & Fast Development of Pharmaceuticals – SNS Insider

    01/22 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Is Pfizer an Absurdly Cheap Dividend Stock, or Just a Value Trap?

    01/22 07:30 am

    The Motley Fool

    Read more
  • New nanoparticle technology offers hope for hard-to-treat diseases

    01/22 12:12 am

    GlobeNewswire Inc.

    Read more
  • Is This Dividend King Stock a Buy After a Major Development?

    01/21 10:30 pm

    The Motley Fool

    Read more
  • High Potency APIs Market Size to Reach USD 58.68 Billion by 2033, Driven by the Increasing Demand for Targeted and Oncology Therapies – SNS Insider

    01/21 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Amyloidosis Therapeutic Market to Worth Over US$ 6.37 Billion by 2033 | Astute Analytica

    01/21 11:54 am

    GlobeNewswire Inc.

    Read more
  • Johnson & Johnson Clears the Patent Cliff as 2026 Guidance Resets the Narrative

    01/21 10:43 am

    Investing.com

    Read more
  • 3 No-Brainer Dividend Stocks to Buy Right Now -- Including Pfizer

    01/21 07:26 am

    The Motley Fool

    Read more
  • U.S. Bispecific Antibodies Forecast Report 2025-2033: Market to Grow by Over $260 Billion, Driven by Increased Cancer and Autoimmune Diseases, FDA Approvals, and Strategic Partnerships

    01/21 05:52 am

    GlobeNewswire Inc.

    Read more
  • Executive Coach Michael King Releases Music Video "Unbreakable Things" on Leadership Identity

    01/20 04:29 pm

    GlobeNewswire Inc.

    Read more
  • GSK To Acquire RAPT Therapeutics In $2.2 Billion Bet On Food Allergy Breakthrough

    01/20 06:54 am

    Benzinga

    Read more
  • Levicept Announces FDA Acceptance of IND Application for LEVI-04, a Potentially Disease-Modifying Treatment for Osteoarthritis

    01/20 05:00 am

    GlobeNewswire Inc.

    Read more
  • Down 55%, Should You Buy the Dip on Pfizer?

    01/19 04:24 pm

    The Motley Fool

    Read more
  • Bioconjugation Market Size to Hit USD 14.51 Billion by 2033, Driven by the Increasing Demand for Targeted Therapeutics – SNS Insider

    01/19 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Sodium Chloride Injections Market, Global Forecast 2026-2032 - Clinical Practice Migration and Manufacturing Modernization are Driving Innovations

    01/19 06:53 am

    GlobeNewswire Inc.

    Read more
  • Women Health & Beauty Supplements Market Analysis and Growth Forecast 2026-2030

    01/19 05:56 am

    GlobeNewswire Inc.

    Read more
  • Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference

    01/14 09:25 pm

    GlobeNewswire Inc.

    Read more
  • Is It Time to Dump Your Shares of Eli Lilly?

    01/14 09:32 am

    The Motley Fool

    Read more
  • Why Tempus AI Stock Rose Today

    01/12 08:07 pm

    The Motley Fool

    Read more
  • Pfizer Cancer Combo Drug Shows Strong Tumor Shrinkage in Colorectal Cancer Trial

    01/12 12:58 pm

    Benzinga

    Read more
  • Prediction: 2 Healthcare Stocks That Will Be Worth More Than Pfizer by the End of 2026

    01/09 10:30 am

    The Motley Fool

    Read more
  • Madrigal Expands its MASH Pipeline with Exclusive Global License Agreement for Ervogastat, a Phase 2 Oral DGAT-2 Inhibitor

    01/09 09:00 am

    GlobeNewswire Inc.

    Read more
  • Merck In Talks To Buy Cancer Drug-Maker Revolution Medicines In A $28 To $32 Billion Deal — Stock Soars Overnight

    01/09 02:52 am

    Benzinga

    Read more
  • Want Over $2,000 in Dividends Each Year? Invest $12,000 Each Into These 3 Stocks

    01/08 12:26 pm

    The Motley Fool

    Read more
  • Warning: This Skyrocketing Stock Has a Hidden Risk

    01/06 09:30 pm

    The Motley Fool

    Read more
  • Motley Fool Money: Stock Market Naughty and Nice List

    01/06 01:33 am

    The Motley Fool

    Read more
  • These 3 Stocks Trade at Discounts the Market Won’t Ignore Forever

    01/05 01:35 pm

    Investing.com

    Read more
  • 2 Predictions for Pfizer in 2026

    01/02 05:30 pm

    The Motley Fool

    Read more
  • Pfizer: Why Wall Street Gave Up—And Why That May Be a Mistake

    01/02 12:24 pm

    Investing.com

    Read more
  • Drugmakers Plan Fresh Price Hikes On 350 Medicines In 2026

    12/31 09:59 am

    Benzinga

    Read more
  • 3 Drug Stocks to Buy at a Discount

    12/27 05:28 pm

    The Motley Fool

    Read more
  • 3 Superb High-Yield Dividend Stocks With Yields North of 5% That Make for No-Brainer Buys Right Now

    12/27 07:30 am

    The Motley Fool

    Read more
  • Got $1,000? 2 High-Yield Healthcare Stocks to Buy and Hold Forever

    12/24 06:26 pm

    The Motley Fool

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: